Key result
A high lactate/albumin ratio was independently associated with an increased risk of 30-day all-cause mortality in patients with acute respiratory failure.
Why the study?
The role of the lactate/albumin ratio as an independent prognostic factor for all-cause mortality in patients with acute respiratory failure remained to be clarified.
Does the lactate/albumin ratio (LAR) predict 30-day all-cause mortality better than individual components or SOFA score in patients with acute respiratory failure?
Observational (n=2,170)
No
Does the lactate/albumin ratio (LAR) predict 30-day all-cause mortality better than individual components or SOFA score in patients with acute respiratory failure?
The lactate/albumin ratio is an easily obtainable biomarker that modestly outperforms lactate alone, albumin alone, and the SOFA score in predicting 30-day mortality among patients with acute respiratory failure.
Answers are grounded in this paper and cite their sources.
May aid risk stratification in acute respiratory failure; leaves open prospective validation beyond existing scores.
Previous studies have shown that lactate/albumin ratio (LAR) can be used as a prognostic biomarker to independently predict the mortality of sepsis and severe heart failure. However, the role of LAR as an independent prognostic factor in all-cause mortality in patients with acute respiratory failure (ARF) remains to be clarified. Therefore, we retrospectively analyzed 2170 patients with ARF in Medical Information Mart for Intensive Care Database III from 2001 to 2012. By drawing the receiver operating characteristic curve, LAR shows a better predictive value in predicting the 30-day mortality of ARF patients (AUC: 0.646), which is higher than that of albumin (AUC: 0.631) or lactate (AUC: 0.616) alone, and even higher than SOFA score(AUC: 0.642). COX regression analysis and Kaplan-Meier curve objectively and intuitively show that high LAR is a risk factor for patients with ARF, which is positively correlated with all-cause mortality. As an easy-to-obtain and objective biomarker, LAR deserves further verification by multi-center prospective studies.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2021) conducted an observational in Acute respiratory failure (n=2,170). High lactate/albumin ratio (≥0.597) vs. Low lactate/albumin ratio (<0.597) was evaluated on 30-day all-cause mortality (HR 1.56, 95% CI 1.33-1.83, p=<0.001). A high lactate/albumin ratio was independently associated with an increased risk of 30-day all-cause mortality in patients with acute respiratory failure.
Synapse has enriched 10 related papers. Consider them for comparative context: